Limited activity: This researcher has not published recently (last publication: 2018). Profile data may be outdated.
Match tier Listed
Presence Current · Arkansas
Last published 2018
Sources OpenAlex · ORCID
Refreshed 2026-08-08

LP Carter

Researcher

UAMS

Also affiliated: University of Arizona (1991); Jazz Pharmaceuticals (United States) (2017–2018)

Faculty Researcher

4 h-index 12 pubs 89 cited

Research Areas

Biomedical Subjects

  • Humans
  • Cerebrovascular Circulation
  • Animals
  • Brain Ischemia
  • Female
  • Middle Aged
  • DNA, Neoplasm
  • DNA, Viral
  • Microsurgery
  • Embolism
  • Fluoresceins
  • Pulmonary Embolism
  • Thrombosis
  • Biomarkers
  • Fluorescein

OverviewAI-generated summary

LP Carter's research has focused on the intersection of health sciences and education. Their work includes investigations into health disparities and outcomes, as well as the impacts of health and medical research. Carter has also explored aspects of higher education research and innovative teaching methodologies within the health sciences.

Metrics

  • h-index: 4
  • Publications: 12
  • Citations: 89

Selected Publications

  • A Randomized, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Solriamfetol (JZP-110) for the Treatment of Excessive Sleepiness (ES) in Participants with Narcolepsy Types 1 and 2 (NT1/2) (CT.003) (2018)
    Neurology 1 citation DOI OpenAlex
  • 0642 A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 IN THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: SF-36 AND EQ-5D-5L MEASURES (2017)
    SLEEP 1 citation DOI OpenAlex
  • 0641 A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, 12-WEEK, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA (2017)
    SLEEP 4 citations DOI OpenAlex
  • 0638 FUNCTION AND WORK PRODUCTIVITY MEASURES IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA (2017)
    SLEEP 3 citations DOI OpenAlex
  • 0675 A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3 STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH NARCOLEPSY (2017)
    SLEEP 4 citations DOI OpenAlex
  • 0644 A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, DOUBLE-BLIND, 6-WEEK MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA (2017)
    SLEEP 2 citations DOI OpenAlex

View all publications on OpenAlex →

Similar Researchers

Based on overlapping research topics

P. A. Moore University of Arkansas at Fayetteville
Health Sciences Research and Education Health Disparities and Outcomes Health and Medical Research Impacts
Strong match 4 shared topics
J. Gibson Graham University of Arkansas for Medical Sciences
Health Sciences Research and Education Health Disparities and Outcomes Health and Medical Research Impacts
Strong match 4 shared topics
Julie Milligan Arkansas State University
Health Sciences Research and Education Health Disparities and Outcomes Higher Education Research Studies
Strong match 4 shared topics
John H. Hall Arkansas State University
Health Sciences Research and Education Health Disparities and Outcomes Higher Education Research Studies
Strong match 4 shared topics
Christine Simecka Morgan University of Arkansas for Medical Sciences
Health Sciences Research and Education Health and Medical Research Impacts Higher Education Research Studies
Strong match 4 shared topics
Sabra Curry University of Arkansas for Medical Sciences
Health Sciences Research and Education Health Disparities and Outcomes Health and Medical Research Impacts
Strong match 3 shared topics